Nektar Therapeutics NKTR
NASDAQ NKTR
$60.57 +1.33 (+2.25%)
As of: Sep 30, 2026 · 11:49 AM EDT

Nektar Therapeutics (NKTR) Operating Expenses (2010 - 2026)

Updated

Nektar Therapeutics' Operating Expenses came in at $52.47 million for Q2 2026, up 10.7% from $47.41 million a year earlier and up 5.1% from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Operating Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nektar Therapeutics reported Operating Expenses of $195.32 million, up 11.2% year-over-year; for FY2025, it came in at $195.33 million, down 4.1% from FY2024.

  • Operating Expenses has declined in each of the last five years, with a five-year compound annual growth rate of -19.5% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $203.63 million in FY2024 (-42.4%), $353.81 million in FY2023 (-24.4%), $468.22 million in FY2022 (-14.6%) and $548.01 million in FY2021 (-5.2%).
  • The Q2 2026 figure represents the highest quarterly Operating Expenses since Q1 2025.
  • Year-over-year, Operating Expenses increased in two of the last eight quarters, with growth averaging 10.1%.
  • The fastest year-over-year change in Operating Expenses over five years came in Q4 2025 (growth of 233.7%), and the weakest in Q4 2024 (a decline of 74.2%).
  • Business Quant data shows NKTR's Operating Expenses at $49.92 million (Q1 2026), $49.47 million (Q4 2025) and $43.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Nektar Therapeutics 2.00 Bn 227.61 Mn - 52.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.47 Mn
Mar 31, 2026 49.92 Mn
Dec 31, 2025 49.47 Mn
Sep 30, 2025 43.46 Mn
Jun 30, 2025 47.41 Mn
Mar 31, 2025 55.00 Mn
Dec 31, 2024 14.83 Mn
Sep 30, 2024 58.47 Mn
Jun 30, 2024 73.26 Mn
Mar 31, 2024 57.07 Mn
Dec 31, 2023 57.40 Mn
Sep 30, 2023 69.01 Mn
Jun 30, 2023 71.10 Mn
Mar 31, 2023 156.30 Mn
Dec 31, 2022 74.49 Mn
Sep 30, 2022 77.93 Mn
Jun 30, 2022 174.42 Mn
Mar 31, 2022 141.38 Mn
Dec 31, 2021 137.92 Mn
Sep 30, 2021 138.52 Mn
API Access

Nektar Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NKTR&period=max&api_key=YOUR_API_KEY